Many medical device design or manufacturing companies may find it difficult to allocate enough time and resources to master the regulatory compliance of medical device, and to compile, maintain,...
Recent Posts
Jouni Toijala, who has worked as CEO at Innokas Medical for almost four years, has decided to pursue new opportunities outside of Innokas. Toijala has been appointed as CEO of listed company...
High quality combined with cost-effective production can be achieved through optimized manufacturability. This requires a wide range of expertise as well as strategic capabilities.
As Finnish and global governments and various medias have communicated, COVID-19 disease, also known as coronavirus, has spread worldwide as a major health threat. In addition, it has already...
Especially now, due to COVID-19, the global demand is high for ventilators and other critical care products. At Innokas Medical, we have readiness and capacity to start the production of critical...
The year 2019 draws to a close and the Christmas Season is just about to begin. Warm thanks for the pleasant cooperation this year. We wish you all a peaceful Christmas time and all the best for...
Danish company Samplix ApS selected Innokas Medical to co-create the novel Xdrop™ instrument for droplet-based PCR-free enrichment of genomic regions.
Great Place to Work organization grants Great Place to Work certification to companies whose Trust Index is at 70 or over it.
“At Innokas Medical, everything begins with the quality built into our processes, products and services. The most important know-how as well as the high standards of our daily operations can be...
